Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iDEA: Determinants of Immunotherapy Efficacy in Endometrial Cancer
NCT07690540Recruiting
- Sponsor
- European Institute of Oncology
- Start
- Apr 2026
- Primary completion
- Apr 2029
- Countries
- 1
01
Overview
Single-arm trial, sponsored by European Institute of Oncology. Primary endpoints: Progression-Free Survival at 2 years and Overall Survival at 2 years. Started Apr 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07690540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07690540.